FDA Official Uses Revolving Door to Join BioTech Company Developing mRNA Vaccines
U.S. Food and Drug Administration (FDA) official Wellington Sun, MD has been hired by biotechnology company Moderna Therapeutics, Inc. of Cambridge, MA to head its Vaccine Strategy and Regulatory Affairs division. Dr. Sun was director of the Division of Vaccines and Related Product Applications at the FDA’s Center for Biologics Evaluation and Research (CBER) where he […]
Drug Companies Pay FDA and NIH to Fast Track and Market Vaccines
When it comes to cozy business relationships between government and industry, there is nothing like the lucrative one that Congress has encouraged federal health agencies to create with the drug and vaccine industry. One hand washes the other. Have you ever wondered how some new drugs and vaccines vault to the front of the line […]
FluMist Vaccine Approved by CDC Without Proof It Works
Story Highlights The CDC recommended against using the live nasal spray FluMist vaccine for the previous two “flu seasons” due to its ineffectiveness against the H1N1 strain. The CDC has done an about-face for the 2018-2019 “flu season” and is back to recommending FluMist again. The CDC’s new recommendation to use FluMist is not backed […]
Global Vaccine Market Expected to Reach $50.52 billion by 2023
The value of the vaccine market will reach $50.42 billion by 2023 from $36.45 billion in 2018, at a Compound Annual Growth Rate (CAGR) of 6.7 percent, according to recently published report by private research firm MarketsandMarkets of India.1 The report provides an overview of the global vaccine market estimating the market size and potential for […]
CDC Accused of Manipulating Shingles Data
The varicella zoster (chickenpox) virus causes a generally mild and short-lived disease when it occurs in young children under age 12, as it almost always did prior to the live attenuated varicella vaccine being licensed in 1995 and recommended by the Centers for Disease Control and Prevention (CDC) for use by all children.1 Natural chickenpox […]
Goldman Sachs Exposes the Cure Dilemma
Story Highlights New gene therapies offer unprecedented hope for permanent cures of serious diseases and hold the promise of an invaluable societal impact. In a report to their biotech clients, investment giant Goldman Sachs questions whether curative therapies are a viable business model. Using Gilead Science’s hepatitis C drug as an example, the report noted […]
